{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-298739","form_type":"8-K","ticker":"CPRX","cik":"0001369568","company_name":"CATALYST PHARMACEUTICALS, INC.","filed_at":"2026-07-08T21:29:46+00:00","discovered_at":"2026-07-08T21:32:00.313208+00:00","generated_at":"2026-07-08T21:32:14.155332+00:00","sec_items":["5.02","5.07"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Catalyst shareholders approve merger with Angelini Pharma; all directors to resign at closing","bullets":["Stockholders approved merger with Angelini Pharma: 97,340,180 votes for, 1,143,815 against, 242,616 abstentions.","Advisory compensation proposal for named executive officers not approved (30.5M for, 67.5M against); non-binding and not a condition to merger.","All seven directors (McEnany, Daly, Curran, Denkhaus, Harper, Thompson, Tierney) to resign effective at merger closing; no disagreement with company.","Merger closing subject to customary conditions; no expected closing date provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-298739","json":"https://secwatch.observer/filing/0001193125-26-298739.json","markdown":"https://secwatch.observer/filing/0001193125-26-298739.md","text":"https://secwatch.observer/filing/0001193125-26-298739.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1369568/000119312526298739/0001193125-26-298739-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1369568/000119312526298739/d109692d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-08T21:32:14.155332+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"00d57ae90f","claim":"Tamar Thompson resigned as Director at CATALYST PHARMACEUTICALS, INC..","evidence_excerpt":"each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1369568/000119312526298739/0001193125-26-298739-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"1ea63cfb5f","claim":"Richard J. Daly resigned as Director at CATALYST PHARMACEUTICALS, INC..","evidence_excerpt":"each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1369568/000119312526298739/0001193125-26-298739-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"3033d52052","claim":"Patrick J. McEnany resigned as Director at CATALYST PHARMACEUTICALS, INC..","evidence_excerpt":"each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1369568/000119312526298739/0001193125-26-298739-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"4593121bdf","claim":"David S. Tierney, M.D. resigned as Director at CATALYST PHARMACEUTICALS, INC..","evidence_excerpt":"each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1369568/000119312526298739/0001193125-26-298739-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"5481d996b8","claim":"Molly Harper resigned as Director at CATALYST PHARMACEUTICALS, INC..","evidence_excerpt":"each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1369568/000119312526298739/0001193125-26-298739-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"bf28b4b710","claim":"Donald A. Denkhaus resigned as Director at CATALYST PHARMACEUTICALS, INC..","evidence_excerpt":"each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1369568/000119312526298739/0001193125-26-298739-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"f31cede2eb","claim":"Daniel J. Curran, M.D. resigned as Director at CATALYST PHARMACEUTICALS, INC..","evidence_excerpt":"each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1369568/000119312526298739/0001193125-26-298739-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}